QBE poised to exceed 2022 net profit
QBE (ASX:QBE) looks set to meet or exceed its 2022 net profit, thanks to a remarkable turnaround in investment returns during the year ending in December.
Read More
QBE is listed on the Australian Securities Exchange (ASX) and headquartered in Sydney. We employ more than 12,000 people in over 31 countries.
QBE is a general insurance and reinsurance company. Across our operations we offer commercial, personal and specialty products and risk management solutions to our customers.
Our purpose is to give people the confidence to achieve their ambitions
Airlie FM's Emma Fisher provides her views on the current market environment and discusses her recent trip to Europe where she visited the HQs of key holdings CSL and QBE Insurance.
WATCH VIDEOQBE (ASX:QBE) looks set to meet or exceed its 2022 net profit, thanks to a remarkable turnaround in investment returns during the year ending in December.
Read More
Amid a surge in catastrophe costs during the first half of 2023, insurance titan QBE (ASX:QBE) demonstrated resilience, driven by robust investment returns and a substantial rise in premium income.
Read More
Airlie FM's Emma Fisher provides her views on the current market environment and discusses her recent trip to Europe where she visited the HQs of key holdings CSL and QBE Insurance.
Read More
With quality management and a strong cycle leading a business turnaround, Joe Wright from Airlie FM explains why he believes insurance major QBE still looks attractive.
Read More
Just when the Australian insurance sector was looking at having escaped any major catastrophe over the holiday break, along comes Friday's flooding event in Auckland.
Read More
The price target is increased to $14.76 from $14.45. The Add rating is unchanged.
Read More
Target price rises to $14.45 from $13.50. Add retained as Morgans sees a positive trajectory over the years forthcoming.
Read More
The broker maintains its Outperform rating and $14.45 target price.
Read More
The Outperform rating and $13.30 target are retained.
Read More
Morgans lifts FY21 and FY22 EPS estimates by 17% and 4%, and raises the target price to $11.83 from $10.78. The Add rating is maintained.
Read More